Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen …
Over the last 12 months, insiders at Inogen, Inc. have bought $0 and sold $85,600 worth of Inogen, Inc. stock.
On average, over the past 5 years, insiders at Inogen, Inc. have bought $0 and sold $29.98M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $42,931 was made by McFarland Loren L (director) on 2019‑09‑04.
2024-05-10 | Sale | EVP, Gen. Counsel & Secretary | 10,000 0.043% | $8.56 | $85,600 | +8.63% | ||
2022-09-01 | Sale | EVP, Chief Technology Officer | 1,576 0.0067% | $28.16 | $44,380 | -47.38% | ||
2022-09-01 | Sale | EVP, Gen. Counsel & Secretary | 1,145 0.0049% | $28.16 | $32,243 | -47.38% | ||
2022-03-03 | Sale | 4,516 0.0199% | $34.68 | $156,619 | -27.73% | |||
2021-09-15 | Sale | director | 4,000 0.0178% | $49.00 | $196,000 | -37.03% | ||
2021-08-16 | Sale | director | 6,594 0.0293% | $62.69 | $413,383 | -49.67% | ||
2021-08-02 | Sale | EVP, Finance, & CFO | 1,397 0.0063% | $80.33 | $112,216 | -59.48% | ||
2021-07-30 | Sale | EVP, Finance, & CFO | 8,235 0.0365% | $80.01 | $658,923 | -60.00% | ||
2021-07-27 | Sale | EVP, Engineering | 7,942 0.0345% | $75.02 | $595,808 | -57.74% | ||
2021-07-27 | Sale | EVP, Finance, & CFO | 9,632 0.0419% | $75.02 | $722,565 | -57.74% | ||
2021-07-15 | Sale | director | 7,000 0.0307% | $65.83 | $460,822 | -50.82% | ||
2021-06-15 | Sale | director | 7,087 0.0307% | $63.81 | $452,212 | -48.87% | ||
2021-06-02 | Sale | 10 percent owner | 680,000 2.9808% | $57.32 | $38.98M | -41.64% | ||
2021-04-15 | Sale | EVP, Engineering | 2,841 0.0126% | $65.21 | $185,252 | -36.23% | ||
2021-04-14 | Sale | EVP, Engineering | 6,104 0.0261% | $60.22 | $367,587 | -33.41% | ||
2021-04-14 | Sale | EVP, Finance, & CFO | 1,641 0.007% | $60.14 | $98,684 | -33.41% | ||
2021-04-13 | Sale | EVP, Engineering | 1,838 0.0083% | $60.00 | $110,280 | -29.81% | ||
2021-04-13 | Sale | EVP, Finance, & CFO | 1,200 0.0054% | $60.00 | $72,002 | -29.81% | ||
2021-03-17 | Sale | EVP, Engineering | 14,765 0.0664% | $51.63 | $762,355 | -8.33% | ||
2021-03-15 | Sale | EVP, Marketing | 7,102 0.0316% | $51.96 | $369,049 | -8.39% |
Lukatch Heath | director | 5481 0.0231% | $9.51 | 1 | 11 | +9% |
McFarland Loren L | director | 4481 0.0189% | $9.51 | 2 | 4 | +19.92% |
Rider Heather D. | director | 1989 0.0084% | $9.51 | 1 | 3 | +49.92% |
Camber Capital Management Lp | $16.14M | 8.48 | 2M | 0% | +$0 | 0.57 | |
Brown Capital Management | $15.94M | 8.38 | 1.98M | +26.59% | +$3.35M | 0.28 | |
BlackRock | $13.5M | 7.1 | 1.67M | -25.31% | -$4.58M | <0.0001 | |
The Vanguard Group | $11.49M | 6.04 | 1.42M | +4.86% | +$532,248.79 | <0.0001 | |
Morgan Stanley | $10.3M | 5.42 | 1.28M | +23.13% | +$1.94M | <0.01 |